This article highlights recent research on breast cancer, lung cancer, melanoma, head and neck cancer, and hematologic malignancies.

The National Institutes of Health (NIH) can continue withholding funding for terminated research grants, the Supreme Court has ruled. 1,2 The court’s decision allows the NIH to withhold the funding ...

Carfilzomib-based regimens outperformed a bortezomib-based regimen in a phase 3 trial of elderly, fit patients with newly diagnosed MM.

The “early promising clinical outcomes” provide a strong basis for further investigation of upright image-guided adaptive proton therapy, according to researchers.

The FDA has authorized the ArteraAI Prostate Test to prognosticate long-term outcomes in patients with non-metastatic prostate cancer.

“he introduction of effective cancer innovations increased population-level health among patients with advanced lung cancer and melanoma but also widened the survival gap across county-level income ...

An analysis of more than 13 million EHR notes revealed evidence suggesting racial bias in how doctors document patient credibility.

The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to ifinatamab deruxtecan (I-DXd) for the treatment of adults with extensive-stage small cell lung cancer (ES-SCLC ...